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Abstract
A variety of physiological and pathological factors induce cellular swelling in the brain. Changes in cell volume activate
several types of ion channels, which mediate the release of inorganic and organic osmolytes and allow for compensatory
cell volume decrease. Volume-regulated anion channels (VRAC) are thought to be responsible for the release of some of
organic osmolytes, including the excitatory neurotransmitters glutamate and aspartate. In the present study, we compared
the in vivo properties of the swelling-activated release of glutamate, aspartate, and another major brain osmolyte taurine.
Cell swelling was induced by perfusion of hypoosmotic (low [NaCl]) medium via a microdialysis probe placed in the rat
cortex. The hypoosmotic medium produced several-fold increases in the extracellular levels of glutamate, aspartate and
taurine. However, the release of the excitatory amino acids differed from the release of taurine in several respects including:
(i) kinetic properties, (ii) sensitivity to isoosmotic changes in [NaCl], and (iii) sensitivity to hydrogen peroxide, which is known
to modulate VRAC. Consistent with the involvement of VRAC, hypoosmotic medium-induced release of the excitatory
amino acids was inhibited by the anion channel blocker DNDS, but not by the glutamate transporter inhibitor TBOA or Cd
2+,
which inhibits exocytosis. In order to elucidate the mechanisms contributing to taurine release, we studied its release
properties in cultured astrocytes and cortical synaptosomes. Similarities between the results obtained in vivo and in
synaptosomes suggest that the swelling-activated release of taurine in vivo may be of neuronal origin. Taken together, our
findings indicate that different transport mechanisms and/or distinct cellular sources mediate hypoosmotic medium-
induced release of the excitatory amino acids and taurine in vivo.
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Introduction
The release of organic osmolytes in response to cellular swelling is
mediatedbyoneormorevolume-sensitivepermeabilitypathways[1–
3]. Although this phenomenon occurs in all tissues, it has special
significance in the brain since two major swelling-sensitive organic
osmolytes, glutamate and taurine, also mediate or modulate neuronal
communication [4–6]. Several neural pathologies, most notably
cerebral ischemia, hyponatremia, hepatic encephalopathy and
traumatic brain injury, are associated with pronounced cell swelling,
which is largely restricted to astrocytes [7–9]. Pathological cell
swelling is likely related to tissue damage since pharmacological
inhibitors that block volume-sensitive anion permeability pathway(s)
suppress the pathological release of the excitatory amino acids,
glutamate and aspartate, and reduce infarct size in animal models of
stroke and ischemia [10–15]. These findings have led to the proposal
that the swelling-activated release of excitatory amino acids may play
a critical role in promoting ischemic tissue damage [7,9,16].
The swelling-induced release of the excitatory amino acids
glutamate and aspartate and the sulfonic acid taurine is thought to
be mediated by Volume Regulated Anion Channels (VRACs),
which are also termed in the literature as Volume Sensitive
Outward Rectifying (VSOR) Cl
2 channels or Volume-Sensitive
Organic osmolyte/Anion Channels (VSOAC) [17–19]. VRACs are
traditionally identified as volume-sensitive Cl
2/anion channels that
are activated in response to cell swelling in nearly all cell types
studied. However, in spite of extensive research efforts, the
molecular identity of these channels remains unknown [19,20].
The major physiological role of VRAC is cell volume regulation.
Upon activation in swollen cells, VRACs mediate the release of
inorganic and organic anions and, in conjunction with swelling-
activated K
+ channels, facilitate reductions in intracellular osmo-
larity and subsequent regulatory volume decrease. In addition to
Cl
2, VRACs are also permeable to bicarbonate (HCO3
2), several
other inorganic anions, as well as small organic osmolytes such as
amino acids, polyols, and methylamines [2,21,22].
The evidence that taurine release is mediated by VRAC, or a
very similar permeability pathway, largely stems from studies in
cultured neuronal and glial cells, which show that both swelling-
activated [
3H]taurine and
125I
2 (Cl
2) fluxes are inhibited by a
variety of VRAC blockers, including the selective VRAC inhibitor
DCPIB [23–27]. Several electrophysiological studies have con-
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conditions when its molecule is negatively charged [21,22,28].
Nevertheless, there is continuous debate as to whether taurine
shares the same permeability pathway with Cl
2 and other anionic
amino acids [29–31]. In particular, in several cell types and in
brain slices, swelling-activated [
3H]taurine efflux shows different
kinetics and pharmacological properties, when compared to Cl
2
(
125I
2) or D-[
3H]aspartate release [32–37].
Although VRAC and VRAC-mediated amino acid fluxes have
been extensively studied in cultured cells, there is limited information
regarding their properties in intact brain tissue. Several studies, which
used perfusion of hypoosmotic medium via microdialysis probes to
induce cell swelling in the brain, found increased extracellular levels
of taurine and several amino acids, which are known to permeate
through VRAC [38–41]. Likewise, Phillis and co-workers found
hypoosmotic medium-stimulated release of taurine and the VRAC-
permeable amino acids using a cortical cup perfusion technique, and
such a release was strongly inhibited by the putative VRAC-blockers
DNDS, NPPB, niflumic acid and tamoxifen [42].
In the present work, we used a microdialysis approach in
anesthetized animals to compare properties of swelling-activated
fluxes of the excitatory amino acids glutamate and aspartate to
those of taurine in the rat cortex in vivo.
Materials and Methods
Animal surgery and microdialysis procedures
All animal procedures performed in this work were approved by
the institution’s animal care and use committee and adhered to the
NIH guidelines for care and use of laboratory animals. Male
Sprague-Dawley rats (Taconic Farms), weighing between 325 and
425 g, were allowed free access to food and water. Rats were given
atropine sulfate (0.5 mg/kg, i.m.) to reduce respiratory tract fluid
secretion, and anesthetized with isoflurane prior to intubation.
Intubated rats were mechanically ventilated with a gas mixture of
2.25% isoflurane in 30% O2/balance N2. A saline drip (0.9%
NaCl) was administered intraperitoneally throughout the exper-
imental procedure to prevent dehydration. Body temperature was
monitored throughout the experiment with a rectal probe and was
maintained between 36uC and 36.5uC with a heating pad.
Animals were placed in a stereotaxic frame and microdialysis
probes (2 mm tip, 20 kD cutoff, CMA Microdialysis, North
Chelmsford, MA, U.S.A.) were slowly lowered through burr holes
into the frontoparietal cortex (from bregma, 1 mm anterior;
64 mm lateral; 2.6 mm down from the dura). Artificial cerebral
spinal fluid (aCSF; in mM: 120 NaCl, 2.7 KCl, 1 MgSO4, 1.2
CaCl2, 25 NaHCO3, 0.05 ascorbic acid; pH=7.3) was perfused at
2 ml/min through the microdialysis probes. After two hours of
probe stabilization at least two 20 minute perfusate samples were
collected by a CMA-170 refrigerated fraction collector (CMA
Microdialysis) to determine baseline amino acid levels before the
application of drug or hypoosmotic medium. Hypoosmotic aCSF
(in mM: 25 NaCl, 2.7 KCl, 1 MgSO4, 1.2 CaCl2, 25 NaHCO3,
0.05 ascorbic acid; pH=7.3) was perfused at 2 ml/min for one
hour and perfusate samples were collected every 5 minutes. Each
rat was implanted with two microdialysis probes placed bilaterally
in the cortex, with one probe serving as a control (hypoosmotic
solution only) and the probe on the other side (chosen at random)
serving as the experimental condition (hypoosmotic solution plus
drug). All drugs were delivered through the microdialysis probes.
Amino acid analysis in microdialysate samples
Dialysate concentrations of the amino acids were determined by
reverse-phase high performance liquid chromatography (HPLC)
using a Hewlett-Packard Series 1100 HPLC system. Pre-column
derivatization of the amino acids was done with o-phthaldialde-
hyde/2-mercaptoethanol. The derivatives were separated using a
C18 Varian column (4.66100 mm, 3 mm particle diameter). The
fluorescence signal was detected by a Hewlett-Packard 1046A
programmable fluorescence detector. Amino acid standards were
used to calculate the concentrations of the amino acids in the
perfusate.
Preparation of primary astrocyte cultures
Confluent primary astrocyte cultures were prepared from the
cerebral cortex of newborn Sprague-Dawley rats as described
elsewhere [43], with minor modifications summarized below.
Newborn Sprague-Dawley rats were euthanized by rapid
decapitation, the cerebral cortices were separated from the
meninges and basal ganglia, and tissue was dissociated using the
neutral protease Dispase II (Roche Applied Science, Indianapolis,
IN, U.S.A.). Dissociated cells were seeded on poly-D-lysine coated
18618 mm glass coverslips (Caroline Biological Supply Co,
Burlington, NC, U.S.A.) for efflux experiments, or 12-well tissue
culture plates for uptake experiments. Cell cultures were grown for
3–4 weeks in Minimal Essential Medium (MEM) supplemented
with 10% heat inactivated horse serum (HIHS), 50 U/ml
penicillin and 50 mg/ml streptomycin at 37uC in a humidified
atmosphere of 5% CO2/95% air. Culture medium was replaced
twice a week. After two weeks of cultivation, penicillin and
streptomycin were removed from the culture medium. Immuno-
cytochemistry showed $95% of the cells stained positively for the
astrocytic marker glial fibrillary acid protein.
Preparation of rat cortical synaptosomes
Rat cortical synaptosomes were isolated from the cortical tissue
of male Sprague-Dawley rats (Taconic Farms) weighing between
180 and 230 g according to [44] with modifications described
elsewhere [45]. Final synaptosomal pellets were resuspended in
HEPES-buffered medium containing (in mM): 135 NaCl, 3.8 KCl,
1.2 MgSO4, 1.3 CaCl2, 1.2 KH2PO4, 10 D-glucose, 10 HEPES;
pH=7.4. Synaptosomes were incubated for 30–40 min at 37uCi n
order to allow them to restore transmembrane ion gradients before
further use in amino acid release experiments.
[
3H]Taurine and D-[
3H]aspartate efflux assays
[
3H]Taurine or D-[
3H]aspartate efflux measurements were
performed in astrocyte cultures as follows. Astrocytes grown on
glass coverslips were loaded overnight with either [
3H]taurine (4
mCi/ml) or D-[
3H]aspartate (4 mCi/ml) in 2.5 ml of MEM
containing 10% HIHS in a CO2 incubator set for 5% CO2/95%
air at 37uC. Before the start of the efflux measurements, the cells
were washed free of extracellular isotope and residual serum-
containing medium in HEPES-buffered solution. The basal
HEPES-buffered medium contained (in mM): 135 NaCl, 3.8
KCl, 1.2 MgSO4, 1.3 CaCl2, 1.2 KH2PO4, 10 D-glucose, 10
HEPES; pH=7.4. The coverslips were inserted into a Lucite
perfusion chamber which had a depression precisely cut in the
bottom to accommodate the coverslip and a Teflon screw top
leaving a space above the cells of around 100–150 mm in height.
The cells were superfused at a flow rate of 1.2 ml/min in an
incubator set at 37uC with isoosmotic or hypoosmotic HEPES-
buffered media. To prepare hypoosmotic medium, the concen-
tration of NaCl was reduced to 85 mM. The osmolarities of all
buffers were checked using a freezing point osmometer (mOsmette,
Precision Systems, Natick, MA, U.S.A.) and were 287–290 and
197–200 mOsm for isoosmotic and hypoosmotic media, respec-
tively. Superfusate fractions were collected at one minute intervals.
Cortical Amino Acid Release
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was extracted with a solution containing 2% sodium dodecyl
sulfate (SDS) plus 8 mM EDTA. Four ml Ecoscint scintillation
cocktail (National Diagnostics, Atlanta, GA, U.S.A.) was added
and each fraction was counted for [
3H] in a Tri-Carb 1900TR
Liquid Scintillation Analyzer (PerkinElmer, Boston, MA, U.S.A.).
Percent fractional isotope release for each time point was
calculated by dividing radioactivity released in each 1-min interval
by the radioactivity left in the cells (the sum of all the radioactive
counts in the remaining fractions up to the beginning of the
fraction being measured, plus the radioactivity left in the cell
digest).
In a few experiments, astrocytes were simultaneously loaded
with D-[
3H]aspartate (2 mCi/ml) and [
14C]taurine (1 mCi/ml) to
compare properties of swelling-activated fluxes of excitatory amino
acids and taurine in one cell preparation. In these instances [
3H]
and [
14C] radioactivity was determined in the same perfusate
samples using a Tri-Carb 1900TR Liquid Scintillation Analyzer
and double-label DPM software.
To measure taurine release in synaptosomal preparations,
synaptosomal suspensions were loaded with [
3H]taurine (0.5 mCi/
ml) for 1 hour at 37uC in basal HEPES-buffered solution. The
extracellular isotope was washed by adding 9 volumes of ice-cold
medium containing (in mM): 243 sucrose, 5 KCl, 1.2 MgSO4,1 0
HEPES, 10 glucose; pH=7.4. Synaptosomes were sedimented
(10,000 g, 2 min at 2uC) and resuspended in the same sucrose
medium, which prevents spontaneous synaptosome depolarization
at low temperatures. Aliquots of [
3H]taurine-loaded synaptosomes
(,0.2–0.3 mg protein) were injected in glass tubes containing
4.5 mL of HEPES-buffered basal, low [NaCl] hypoosmotic, or low
[NaCl] isoosmotic media, as specified in the Results section. After
5-min incubation at 37uC, taurine efflux was terminated by rapid
vacuum filtration through GF/C glass microfiber filters (What-
man-GE Healthcare, Florham Park, NJ, U.S.A.). Filters were
placed in scintillation vials containing a 4 ml Ecoscint scintillation
cocktail and counted for radioactivity remaining in the synapto-
somes. Relative taurine efflux values (% loaded/5 min) were
calculated by comparing the radioactivity in experimental samples
to isotope content in samples filtered through GF/C without
incubation at 37uC (‘‘0 time’’).
[
3H]Taurine and D-[
3H]aspartate uptake assay
Cultured astrocytes for these experiments were grown in 12-well
tissue culture plates according to the cell culture method described
in the previous section. Serum-containing medium was washed
out, and the cells were incubated for 30 minutes at 37uC with
basal HEPES-buffered medium containing 0.5 mCi/mL of
[
3H]taurine or D-[
3H]aspartate plus 10 mM of unlabeled taurine
or L-glutamate, respectively. Following the 30-min incubation
period cells were washed four times with ice-cold physiological
phosphate buffered solution. Cells were then lysed with 2% SDS
plus 8 mM EDTA. The isotope content in the lysate was used as a
measure of taurine ([
3H]taurine) or L-glutamate (D-[
3H]aspartate)
uptake. Four ml Ecoscint scintillation cocktail was added to each
lysates and [
3H] was counted in a Liquid Scintillation Analyzer.
Statistical analysis
The statistical significance of the differences in the amino acid
release and uptake were determined with ANOVA or repeated
measures ANOVA, as specified throughout the text and in figure
legends. For the in vivo experiments, planned comparisons were
performed with repeated measures ANOVA to determine differ-
ences in amino acid release only during hypoosmotic medium
exposure. Origin 7.5 (OriginLab, Northampton, MA) and Statistica
6.1 (StatSoft, Tulsa, OH) were used for statistical analysis.
Chemicals
Cadmium chloride (CdCl2), hydrogen peroxide (H2O2), man-
nitol and ouabain were purchased from Sigma (St. Louis, MI,
U.S.A). [
3H]Taurine or D-[
3H]aspartate were from GE Health-
care-Amersham (Buckinghamshire, U.K.). DL-Threo-b-benzylox-
yaspartic acid (DL-TBOA) was obtained from Tocris (Ellisville,
MI, U.S.A.). 4,49-dinitrostilbene-2,29-disulfonic acid, disodium salt
(DNDS) and all cell culture reagents were from Invitrogen
(Carlsbad, CA, U.S.A.). All other chemicals including amino acid
standards for the HPLC experiments were purchased from Sigma
or Aldrich (Milwaukee, WI, U.S.A.) and were the highest purity
available.
Results
Differences in kinetics of cortical amino acid and taurine
release in response to perfusion of hypoosmotic medium
or low NaCl isoosmotic medium
In order to examine volume-sensitive amino acid release in vivo,
rat cortices were perfused via a microdialysis probe with
hypoosmotic medium in which [NaCl] was reduced from 120 to
25 mM NaCl (65% reduction in osmolarity; medium also
contained 25 mM NaHCO3 and other salts as specified in the
Methods section). We used a larger reduction in medium
osmolarity compared to that typically employed in vitro to account
for the fact hypoosmotic media perfused via microdialysis probes
are gradually diluted with the extracellular fluids upon their
diffusion in the brain. Hypoosmotic medium initiated substantial
increases in the levels of VRAC-permeable glutamate, aspartate
and taurine (Fig. 1a–c). In the same experiments the extracellular
levels of the VRAC-impermeable amino acids, asparagine and
glutamine, were either downregulated (glutamine) or not altered
(asparagine) by the hypoosmotic medium (Fig. 1d–e). Increases in
the extracellular levels of glutamate and aspartate had similar
kinetics. Dialysate levels of both amino acids peaked at 15 minutes
(,6.5- and ,5-fold increases over baseline, for glutamate and
aspartate, respectively), then quickly decreased to levels which
were only 2-3-fold higher than the basal release, with additional
recovery observed after switching to isoosmotic medium (Fig. 1a,
b). In contrast, in the same samples, the swelling-activated release
of taurine was consistently delayed by 5 minutes versus excitatory
amino acids, had a substantially slower inactivation, and never
recovered after returning to isoosmotic conditions (Fig. 1c).
To determine if the increases in glutamate, aspartate and
taurine levels were due to changes in osmolarity or a consequence
of reduced [NaCl]e, the same rats were simultaneously perfused,
via microdialysis probes placed in the contralateral cortex, with
low [NaCl] (25 mM) medium that was made isoosmotic by the
addition of 167 mM mannitol. The isoosmotic low [NaCl]
medium failed to induce an increase in dialysate concentrations
of glutamate and aspartate (Fig 1a, b). In the same samples,
however, we found a large increase in the extracellular levels of
taurine in response to isoosmotic [NaCl]e reduction, which was
not statistically different from the hypoosmotic-stimulated aug-
mentation (Fig 1c).
In order to understand the nature of the low [NaCl]-induced
taurine release, we exposed cultured astrocytes and isolated nerve
endings (synaptosomes) prepared from rat cortical tissue to low
[NaCl] media made isoosmotic with mannitol. In striking contrast
to the in vivo microdialysis data, cultured astrocytes preloaded with
[
3H]taurine failed to show any increase in taurine release levels
Cortical Amino Acid Release
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(Fig 2a). In cortical synaptosomes, we found modest (,3-fold)
increases in [
3H]taurine release under isoosmotic low [NaCI]
conditions (2b). However, such increases were much smaller when
compared to the releases induced by the hypoosmotic reduction in
[NaCI] (,15 fold, Fig. 2b). This was in contrast to our in vivo data
which showed very similar increases in taurine levels with both
hypoosmotic and isoosmotic low [NaCl] medium (compare Figs 2b
and 1c).
Since taurine transporter function is dependent on the
transmembrane Na
+ gradient, we speculated that the increased
levels of taurine seen in vivo upon application of low extracellular
[NaCl] hypoosmotic or isoosmotic media may in part be due to
inhibition of the taurine transporter. To address this issue, we
evaluated how decreases in [Na
+]e affect [
3H]taurine uptake in
cultured astrocytes. Given that glutamate and aspartate levels in
vivo are insensitive to the isoosmotic decrease of [Na
+]e (see Fig. 1a,
b), we additionally compared the effect of low [Na
+]e on
[
3H]taurine uptake to the uptake of D-[
3H]aspartate. As seen in
Fig. 3, decreases in [Na
+]e to 50 mM (equivalent to the low [Na
+]e
used in the in vivo experiments) significantly inhibited both
[
3H]taurine and D-[
3H]aspartate (L-glutamate) uptake, with
taurine uptake inhibited to a greater extent. However, the
observed in vitro difference in the transporters’ sensitivities to
[Na
+]e may not in itself be sufficient to explain the drastic
sensitivity of taurine release to isoosmotic modulation of the
[NaCl] observed in vivo.
Effects of the anion channel blocker DNDS on
hypoosmotic medium-stimulated amino acid and taurine
release in vivo and in vitro
Given that our data show that taurine and excitatory amino
acid levels are differentially regulated in vivo by low [NaCl], we
further investigated the potential mechanisms responsible for the
elevated amino acid levels in response to hypoosmotic medium by
using different amino acid transport inhibitors. Our first aim was
to determine if the increases in extracellular excitatory amino acid
levels is mediated by a VRAC-like pathway, as has been
extensively shown in vitro. Therefore, we used the anion channel
blocker DNDS, which has an IC50 for VRACs of ,1–2 mM [46].
Although DNDS has a low potency for inhibiting VRACs, it is one
of the few anion channel inhibitors that can be used in
microdialysis studies because it does not produce toxic effects or
changes in the basal amino acid release levels. The more potent
VRAC blockers NPPB or phloretin caused strong and progressive
increases in microdialysate glutamate and aspartate levels, which
likely reflect cytotoxicity (Y. Jin, R.E. Haskew-Layton, P.J. Feustel,
H.K. Kimelberg, A.A. Mongin, unpublished observations). Ten
mM DNDS, when added one hour prior to and during
hypoosmotic medium exposure, significantly inhibited the hypo-
osmotic-stimulated release of the excitatory amino acids glutamate
and aspartate, but did not alter basal excitatory amino acid levels
(Fig 4a, b). DNDS also potently inhibited hypoosmotic taurine
release, and in addition, also reduced taurine levels under basal
conditions (Fig. 4c).
Figure 1. Effect of hypoosmotic or isoosmotic low [NaCl] medium on amino acid levels measured in the rat cortex in vivo. (a–c)
Microdialysis probes, implanted in the rat frontoparietal cortex, were perfused with hypoosmotic medium (295 mM NaCl, 265% osmolarity) or
isoosmotic low NaCl medium (295 mM NaCl +167 mM mannitol) for one hour. In these experiments, the rat brain was perfused with both the
hypoosmotic and isoosmotic medium on opposite sides of the cortex. The data represent average dialysate levels of glutamate (a), aspartate (b), and
taurine (c) 6SEM from 5 rats. ** p,0.01, hypoosmotic vs. isoosmotic low [NaCl], repeated measures ANOVA. (d–e) In several experiments dialysate
levels of glutamine (d, N=5), and asparagine (e, n=3) were additionally measured on the ‘‘hypoosmotic’’ side of the brain.
doi:10.1371/journal.pone.0003543.g001
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the effect of DNDS on swelling-activated D-[
3H]aspartate release
in cultured astrocytes, which is entirely mediated by VRACs [47].
Two mM DNDS was sufficient to suppress D-[
3H]aspartate
release by ,70% (Fig. 5a), was similarly effective against astrocytic
[
3H]taurine release (,75%, data not shown), and nearly
completely suppressed swelling-activated [
3H]taurine release from
cortical synaptosomes (Fig. 5b). To further explore whether DNDS
may inhibit taurine transporters and in this way affects
extracellular taurine levels in vivo, we tested the effects of DNDS
on taurine uptake in cultured astrocytes. DNDS did not affect
astrocytic [
3H]taurine uptake up to the concentration of 32 mM,
suggesting that this compound does not alter taurine transporter
function (data not shown).
Effects of the Ca
2+ channel blocker Cd
2+ on hypoosmotic
medium-stimulated amino acid and taurine release in
vivo
To additionally explore the mechanisms responsible for the
excitatory amino acid release in vivo, we tested for the contribution
of alternative release mechanisms. One such mechanism is
synaptic Ca
2+-dependent release from a vesicular pool. Several
reports suggest that hypoosmotic medium induces membrane
depolarization and promotes increases in [Ca
2+]i in synaptosomes
and brain slices, which may trigger exocytotic neurotransmitter
release [48–50]. To exclude the possible involvement of exocytosis
in mediating hypoosmotic-induced amino acid release we used a
broad spectrum blocker of voltage-sensitive Ca
2+ channels,
cadmium (Cd
2+). Ca
2+-free artificial cerebral spinal fluid contain-
ing 300 mMC d
2+, given 20 minutes prior to and during Ca
2+-free
hypoosmotic medium perfusion, did not alter glutamate, aspartate
or taurine release (Fig. 6a–c). Previous studies have found that
300 mMC d
2+, administered through microdialysis probes, is
effective in blocking electrically stimulated serotonin release and
membrane depolarization-induced norepinephrine release
[51,52], and 30 mMC d
2+ is sufficient to reduce tonic glutamate
release in the amygdala [53]. Thus, our data showing that amino
acid release in vivo is insensitive to 300 mMC d
2+ suggests that
hypoosmotic-stimulated excitatory amino acid release is not due to
the stimulation of exocytosis.
Effects of the glutamate transporter blocker DL-TBOA on
hypoosmotic medium-stimulated excitatory amino acid
release in vivo
Low [Na
+]e may potentially elevate dialysate glutamate and
aspartate levels by inducing the reversal of glutamate transporters,
Figure 2. Isoosmotic low [NaCl] medium does not induce
taurine release from cultured rat astrocytes but modestly
enhances taurine release from rat cortical synaptosomes. (a)
Effect of hypoosmotic or isoosmotic reductions in [NaCl] on [
3H]taurine
release from astrocytes. The data represent mean values 6SEM of
integral 10-min releases under isoosmotic (Basal), hypoosmotic (Hypo),
or isoosmotic low [NaCl] solutions. n=4 for each group. *p,0.05,
***p,0.001, vs. basal. (b) Integral 5-min releases of [
3H]taurine from
synaptosomes exposed to isoosmotic (Basal), hypoosmotic (Hypo) or
isoosmotic media with lowered [NaCl]. Means 6SEM of 3 experiments.
** p,0.01, vs. basal.
doi:10.1371/journal.pone.0003543.g002
Figure 3. Dependence of taurine and glutamate uptake on
extracellular [Na
+] in cultured astrocytes. Taurine and glutamate
transport rates were measured in primary astrocyte cultures using
[
3H]taurine and D-[
3H]aspartate. Extracellular concentrations of amino
acids were adjusted to 10 mM using unlabeled taurine or L-glutamate.
T oc o m p a r eg l u t a m a t ev e r s u st a u r i n eu p t a k e ,t h ev a l u e sw e r e
normalized to uptake levels under basal conditions ([Na
+]o=135 mM).
Note that under basal conditions absolute D-[
3H]aspartate uptake rate
(nmols/mg protein) was ,5-fold higher compared to taurine. Data are
the mean values 6SEM of three experiments from each group.
doi:10.1371/journal.pone.0003543.g003
Cortical Amino Acid Release
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+ and K
+ gradients [54].
Therefore to rule out the involvement of glutamate transport
reversal in mediating hypoosmotic-stimulated excitatory amino
acid release we used the broad-spectrum non-transportable
glutamate transporter blocker DL-TBOA that blocks all neuronal
and glial transporters [55,54]. 500 mM DL-TBOA given 20 min-
utes prior to and during hypoosmotic medium perfusion,
significantly increased rather than decreased excitatory amino
acid release and did not affect taurine levels (Fig. 7a, b), suggesting
that normal transport operation is maintained under hypoosmotic
conditions and transport reversal is not responsible for the
hypoosmotic medium-stimulated excitatory amino acid release.
As expected, the in vivo extracellular levels of taurine were not
affected by DL-TBOA (data not shown).
Although DL-TBOA has been well characterized as an
inhibitor of normal glutamate transporter function [55], we
wanted to verify DL-TBOA’s effectiveness in blocking glutamate
transporters working in the reverse mode. Cultured astrocytes,
preloaded with D-[
3H]aspartate, were treated for 40 minutes with
1.0 mM ouabain to increase [Na
+]i, prior to and during
20 minutes perfusion with an isoosmotic 100 mM [K
+]e medium.
These treatment conditions have previously been shown to induce
the reversal of glutamate transporters in cultured astrocytes [56].
In vitro, 300 mM DL-TBOA given 10 minutes prior to and during
10 mM [K
+] perfusion completely blocked glutamate transport
reversal-induced D-[
3H]aspartate release, verifying that DL-
TBOA is an effective inhibitor of glutamate transport reversal
(Fig. 7c).
Effects of H2O2 on hypoosmotic-stimulated release of
excitatory amino acid and taurine in vivo and in vitro
We further investigated if reactive oxygen species modulate
swelling-sensitive excitatory amino acid release in the brain, as
seen in cultured astrocytes (Haskew-Layton et al., 2005). One mM
H2O2, administered 20 minutes prior to and during hypoosmotic
medium perfusion, did not affect basal levels of glutamate or
aspartate but significantly enhanced the swelling-evoked release of
both excitatory amino acids (Fig. 8a,b). In contrast, H2O2 did not
alter dialysate levels of taurine under hypoosmotic conditions
(Fig. 8c), suggesting that excitatory amino acids and taurine release
are differentially regulated. To verify that H2O2 does not
upregulate glutamate and aspartate release via a VRAC-
independent mechanism, we tested the effects of 1 mM H2O2
on amino acid levels in the absence of hypoosmotic medium in a
separate set of experiments. As seen in Fig. 8a, b, when superfused
under isoosmotic conditions, 1 mM H2O2 did not produce a
substantial increase in excitatory amino acid levels but did cause a
small gradual upward shift in the baseline.
Since H2O2 has been reported to alter glutamate uptake [57],
we tested the effects of 1–1,000 mMH 2O2 on the excitatory amino
acid uptake in cultured astrocytes. H2O2 did not alter the
excitatory amino acid uptake in vitro up to the highest
concentration tested (data not shown). These data, in conjunction
with the lack of a H2O2 effect on the basal levels of excitatory
amino acid in vivo, suggest that the effects of H2O2 on hypoosmotic
glutamate and aspartate levels are unlikely due to uptake
inhibition.
In order to model the effects of H2O2 on taurine release in
astroglial and neuronal cells, we tested in vitro the effect of 300 mM
H2O2 on swelling-activated amino acid release in cultured rat
astrocytes and cortical synaptosomes. Astrocytes were simulta-
neously preloaded with D-[
3H]aspartate and [
14C]taurine to
reveal any potential differences between release properties of the
excitatory amino acids and taurine in the same cells. As in our
previous study (Haskew-Layton et al., 2005), H2O2 strongly
potentiated the swelling-induced release of D-[
3H]aspartate (data
not shown), as well as the release of taurine (Fig. 9a) by 2-3-fold. In
striking contrast, the same concentration of H2O2 was completely
ineffective in potentiating [
3H]taurine release in synaptosomes,
whether H2O2 added 10 minutes before and during application of
hypoosmotic medium (Fig. 9b) or acutely (data not shown). These
results suggest that the H2O2-insensitive, hypoosmotic-medium
stimulated taurine release observed in vivo may originate from a
neuronal compartment.
Discussion
In the present in vivo study we employed a microdialysis
approach to compare properties of the swelling-activated release of
major organic osmolytes, the excitatory amino acids glutamate
and aspartate and the sulfonic acid taurine, in the rat cortex.
Swelling-activated amino acid release may mimic pathological
processes that occur in ischemia and several other neuropathol-
ogies, where extensive astroglial cell swelling has been detected
[7,9]. To model the effects of cell swelling without the contribution
Figure 4. Effect of the anion channel blocker DNDS on hypoosmotic medium-induced amino acid release in the rat cortex. (a–c)
Microdialysis probes were perfused on opposite sides of the cortex with hypoosmotic medium (HYPO, 265% osmolarity) in the presence or absence
of 10 mM DNDS, given one hour prior to and during one-hour hypoosmotic medium perfusion. The data represent average dialysate levels of
glutamate (a), aspartate (b) and taurine (c) +/2SEM from 5 rats. * p,0.05, HYPO vs. HYPO+DNDS (glutamate); ** p,0.01, HYPO vs. HYPO+DNDS
(aspartate); *** p,0.001 HYPO vs. HYPO+DNDS (taurine). Significance was determined by repeated measures ANOVA.
doi:10.1371/journal.pone.0003543.g004
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utilized perfusion of hypoosmotic medium via a microdialysis
probe, rather than performing the studies in the ischemic brain.
The major finding of our work is that hypoosmotic-medium
induced release of excitatory amino acids and taurine exhibit
significant differences in their kinetic properties, sensitivity to
isoosmotic changes in extracellular [NaCl] and response to
perfusion of the reactive oxygen species H2O2. Such differences
indicate that these organic osmolytes are released from different
cellular pools and/or via different release pathways.
Properties of hypoosmotic medium-induced excitatory
amino acid release are consistent with the involvement
of VRAC
Previous findings from the literature suggest that there is
substantial similarity between swelling-activated amino acid
release in vitro and in situ. In cultured astrocytes and neuronal
cells, hypoosmotic medium promotes cell swelling and triggers the
release of several uncharged or negatively charged amino acids
such as glycine, alanine, taurine, glutamate, and aspartate
[23,24,26,47,58,59]. Several in situ studies performed in brain
slices have found that the release properties of isotope-labeled and
endogenous excitatory amino acids and taurine are similar to those
observed in vitro [36,60–62]. Such organic osmolyte release occurs
via a non-saturable pathway, which is inhibited by a variety of Cl
2
channel blockers, and therefore likely mediated by an anion
channel. In vitro electrophysiological studies found that volume-
regulated anion channels (VRAC) are permeable to glutamate,
aspartate, taurine, and glycine, but not to the majority of other
amino acids [21,22,63–65]. However, it is currently debated
whether one or more permeability pathways contribute to the
release of organic osmolytes [29–31]. Furthermore, some reports
additionally proposed that hypoosmotic swelling may promote the
release of excitatory amino acids via a Ca
2+-independent mode of
exocytosis [66,67].
In vivo, our present work and several previous studies found that
hypoosmotic medium stimulates the release of VRAC-permeable
amino acids (glutamate, aspartate, and taurine), while the levels of
VRAC-impermeable amino acids (e.g., asparagine and glutamine)
remain unaffected or decreased [38,39,42]. The broad spectrum
Cl
2 channel blocker DNDS inhibited the release of excitatory
amino acids and taurine, at concentrations that block VRAC
activity in vitro. We have found that DNDS is well tolerated in vivo,
unlike other commonly used and more potent VRAC blockers,
such as NPPB and phloretin. Consistent with the involvement of
VRAC, increases in the extracellular levels of the excitatory amino
acids were seen upon application of hypoosmotic medium (low
[NaCl]e) but not in response to isoosmotic changes in [NaCl]e
(NaCl replaced with mannitol). Furthermore, swelling-induced
excitatory amino acid release was not blocked by inhibitors of two
alternative glutamate and aspartate release pathways, i.e. reversal
of glutamate transporters and exocytotic release.
Although cell swelling is thought to be the primary stimulus
responsible for initiating VRAC opening in the pathological brain,
little else is known about the activation or modulation of VRACs
in the intact tissue. Our recent in vitro work demonstrated that
swelling activated excitatory amino acid release via VRAC is
potently modulated by reactive nitrogen species and reactive
oxygen species [68,69]. In the present microdialysis experiments,
the reactive oxygen species H2O2 strongly increased hypoosmotic
levels of glutamate and aspartate, but had little effect when
administered under isoosmotic conditions. Taken together with
the pharmacological data, these findings are in line with the idea
that VRAC is the primary source of the excitatory amino acid
release in response to hypoosmotic medium-induced (and
pathological) cell swelling.
Hypoosmotic medium-induced release of taurine differs
from the excitatory amino acid release
Unexpectedly, we found marked differences in taurine and
excitatory amino acid release. Taurine is widely regarded as an
important osmoregulatory molecule in the brain and in other
tissues because it is one of the most abundant organic osmolytes
and effectively permeates a putative VRAC-like pathway
Figure 5. Effect of DNDS on swelling-activated D-[
3H]aspartate
release from cultured astrocytes and swelling-activated
[
3H]taurine uptake in cortical synaptosomes. (a) Cultured
astrocytes preloaded with D-[
3H]aspartate were superfused with
hypoosmotic medium in the presence or absence of 2 mM DNDS.
The data are the mean values of five experiments for each group 6SEM.
*** p,0.001 hypo, vs. DNDS. (b) Release of preloaded [
3H]taurine from
cortical synaptosomes was measured under isoosmotic (BASAL) and
hypoosmotic (HYPO) conditions in the presence or absence of 2 mM
DNDS. The data are the mean values of integral 10-min [
3H]taurine
release 6SEM of three experiments performed in quadruplicate.
***p,0.001 vs. isoosmotic control (BASAL),
###p,0.001 vs. hypoos-
motic control (HYPO).
doi:10.1371/journal.pone.0003543.g005
Cortical Amino Acid Release
PLoS ONE | www.plosone.org 7 October 2008 | Volume 3 | Issue 10 | e3543Figure 6. Effect of the Ca
2+ channel blocker Cd
2+ on hypoosmotic medium-induced amino acid release in the cortex. (a–c)
Microdialysis probes were perfused with hypoosmotic medium (HYPO) in the presence or absence of 300 mMC d
2+ given 20 minutes prior to and
during one-hour hypoosmotic medium perfusion. Each rat had two microdialysis probes implanted on opposite sides of the cortex (one perfused
with HYPO alone and the other with HYPO+Cd
2+). The data represent the average dialysate levels 6SEM of glutamate (a), aspartate (b), and taurine
(c) from 5 rats.
doi:10.1371/journal.pone.0003543.g006
Figure 7. Effect of the glutamate transporter inhibitor DL-TBOA on hypoosmotic medium induced amino acid release in the cortex
and glutamate transporter reversal in cultured astrocytes. (a–b) Microdialysis probes implanted on opposite sides of the cortex were
perfused with hypoosmotic medium in the presence or absence of 500 mM DL-TBOA, given 20 minutes prior to and during one hour hypoosmotic
medium perfusion. The data represent average dialysate levels of glutamate (a), aspartate (b) 6SEM from 4 rats. ** p,0.01 HYPO vs. HYPO+TBOA. (c)
DL-TBOA effectively prevented reversal of glutamate transporter in cultured astrocytes. Cultured astrocytes were superfused for one hour with 1 mM
ouabain and additionally for 20 min high [KCl] (100 mM) plus ouabain to induce glutamate transporter reversal. 300 mM DL-TBOA was given
10 minutes prior to and during the high [KCl] perfusion in the presence of ouabain. The data are the average values 6SEM for three experiments in
each group. ** p,0.01 KCl vs. KCl+TBOA.
doi:10.1371/journal.pone.0003543.g007
Figure 8. Effect of H2O2 on hypoosmotic medium induced amino acid release in the cortex. (a–c) Two microdialysis probes implanted on
opposite sides of the cortex were perfused with hypoosmotic medium in the presence or absence of 1 mM H2O2 given 20 minutes prior to and
during one-hour hypoosmotic medium perfusion. The data represent the average dialysate levels 6SEM of glutamate (a), aspartate (b) and taurine
(c) from 9 rats. ** p,0.01 HYPO vs. HYPO+H2O2. In separate experiments, rats were perfused with 1 mM H2O2 alone (N=5).
doi:10.1371/journal.pone.0003543.g008
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release in cultured astrocytes, hippocampal slices, and in vivo
microdialysis experiments has been found to be potently
upregulated under hypoosmotic conditions (reductions in [Na-
Cl]e), but is insensitive to isoosmotic changes in [NaCl]e
[23,41,66]. Therefore, our observation, that cortical taurine levels
are strongly elevated by either hypoosmotic or isoosmotic low
[NaCl] media, was rather surprising. Nevertheless, such a finding
is not unique. A similar sensitivity of taurine to changes in [NaCl]e
independent of changes in osmolarity has been found in two
microdialysis studies measuring taurine levels in the rat hippo-
campus and in slices prepared from the mouse brain stem [71,72].
Using an alternative approach, in which extracellular amino acids
were sampled via a cortical cup, Phillis et al. also observed that
replacement of extracellular NaCl with choline-Cl or MMDG-Cl
strongly elevated superfusate levels of taurine but not those of
glutamate or aspartate [73].
Besides the differences in sensitivity to isoosmotic [NaCl]e
decreases, taurine release was (i) consistently delayed by ,5 min-
utes, compared to the swelling-activate release of the excitatory
amino acids, (ii) showed much slower inactivation, and (iii) was
completely insensitive to the application of H2O2. Since the amino
acid measurements were performed in the same samples, these
data unequivocally point to different release mechanisms or
different cellular sources. The idea of diverse transport pathways
for taurine and other osmolytes has been suggested in the past,
based on dissimilar properties of taurine and excitatory amino acid
release in cultured astrocytes, hippocampal brain slices, and in a
mammary cell line [35,66,74]. However, because the molecular
identity of the volume-sensitive organic osmolyte release pathway
is unknown, this hypothesis is difficult to address.
An alternative hypothesis that would explain the atypical
behavior of taurine is that in the cortex taurine and excitatory
amino acids are released from different cellular pools. Glutamate is
uniformly distributed in the brain, however it is somewhat more
concentrated in neurons since its concentration in astrocytes is
lowered by the activity of glutamine synthase [75]. In contrast, the
cellular localization of taurine is highly heterogeneous. Depending
on the brain region, taurine is concentrated within either glial cells
or neurons. For instance, in the cerebellum and the putamen
taurine is primarily localized to neurons, while in the thalamus,
hypothalamus and brain stem it is concentrated in glial cells [76–
78]. In the cortex there have been conflicting reports suggesting
that taurine is preferentially localized to either neurons or glial
cells [79,80].
In order to model properties of astroglial and neuronal taurine
release we performed experiments in primary rat astrocytes and
cortical synaptosomes. In cultured astrocytes, taurine release was
completely dissimilar to the release in vivo: it was absolutely
insensitive to isoosmotic decreases in [NaCl]e, and was strongly
potentiated by H2O2 in swollen cells. Since we were unable to
mimic the astrocytic profile of taurine release in vivo, it suggests that
astrocytes may contribute to only a negligible portion of taurine
release in the cortex. On the other hand, similar to our in vivo data,
swelling-activated taurine release in synaptosomes mimicked the in
vivo release in that it was completely insensitive to H2O2 and
sensitive to isoosmotic reductions in [NaCl]e (albeit to a much
weaker degree than the in vivo response). Although these
synaptosomal data do not perfectly match the in vivo results, they
suggest a possibility that taurine release in the cerebral cortex
originates from a neuronal pool. Ineffective uptake of extracellular
taurine in vivo under hypoosmotic conditions and in response to
isoosmotic reductions in [NaCl] may be determined by a lower
density of taurine transporters and their high dependence on
extracellular [Na
+] and [Cl
2] (see Fig. 3). In contrast, glutamate
transporters are expressed at a very high density in the brain and
driven by the transmembrane gradients of K
+,N a
+, and Cl
2, and
are therefore less sensitive to changes in [NaCl]e [54,75]. An
integrated model, providing an explanation for our in vivo and in
vitro data, is presented in Fig. 10.
Relevance to pathophysiological amino acid and taurine
release in ischemia
There is ample evidence that VRAC contributes to pathological
excitatory amino acid release in a number of neurological
conditions associated with cell swelling, including ischemia,
hyponatremia, hepatic encephalopathy, and traumatic brain
injury (reviewed in [7,9]). In animal ischemia models, VRAC
blockers reduce pathological elevations in the extracellular levels of
excitatory amino acids [10,11,14,81], and potently protect the
animal brain against ischemic damage [12,82,83]. Most recently,
Figure 9. Effect of H2O2 on swelling-activated taurine release
from cultured astrocytes and cortical synaptosomes. (a) The
effect of H2O2 on swelling-activated [
14C]taurine release from cultured
astrocytes. Astrocytes were preloaded overnight with [
14C]taurine and
D-[
3H]aspartate. 300 mMH 2O2 was added to the media 10 min before
and during exposure to hypoosmotic medium. For clarity, only
[
14C]taurine release is shown. The data are the mean values 6SEM of
three experiments. **p,0.01 vs. hypotonic control. (b) The effect of
H2O2 on swelling activated [
3H]taurine release from rat cortical
synaptosomes. Integral [
3H]taurine release was measured for 5 minutes
as described in Material and methods. 300 mMH 2O2 was present in
media 10 min before and during measurements of taurine release. Data
are the mean values 6SEM of three independent experiments
performed in quadruplicate. ***p,0.001 vs. basal release.
doi:10.1371/journal.pone.0003543.g009
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intra-ischemic glutamate release and potently reduce ischemic
infarction in a rat focal reversible ischemia model [15]. Consistent
with in vivo findings, in a slice model of cerebral spreading
depression, VRAC inhibitors delay the onset of glutamate-
dependent depolarizations and reduce glutamate release, which
is at least partially associated with cell swelling [84]. Interestingly,
characteristics of intra-ischemic taurine release also show strong
deviation from those of glutamate and aspartate. For instance, in a
rat global ischemia model ischemic striatal taurine release was
weekly sensitive to 1 and 10 mM DNDS, as compared to the
strong inhibition of pathological excitatory amino acid release
[11]. Although in the present experiments, both the hypoosmotic
release of taurine and the excitatory amino acids were potently
suppressed by DNDS, the global ischemia data are consistent with
the idea that taurine and excitatory amino acids may be released
from different cellular pools and/or via different transport
mechanisms. Properties of swelling activated excitatory amino
acid release in vivo strongly resembled the positive modulation of
the excitatory amino acid release via a putative VRAC pathway,
and in particular were strongly upregulated by H2O2, as seen in
cultured astrocytes [69]. Since H2O2 levels are strongly upregu-
lated in ischemia and reperfusion [85,86], the additive effects of
cell swelling and reactive oxygen species may contribute to
excitotoxic tissue damage in stroke and perhaps other neuropa-
thologies.
In summary, we found that cellular swelling in the rat cortex in
vivo triggers release of glutamate and aspartate with properties
strongly resembling swelling-activated excitatory amino acid
release in cultured astrocytes, which is thought to be mediated
by VRAC [47]. In contrast, hypoosmotic medium-induced taurine
release seemingly is derived from a different cellular source or
mediated by different transporter mechanism(s). Since taurine
release properties could be mimicked in synaptosomal prepara-
tions, we speculate that such release may originate from a
neuronal compartment.
Author Contributions
Conceived and designed the experiments: REHL AR AAM. Performed the
experiments: REHL AR YJ. Analyzed the data: REHL AR PJF HK AAM.
Contributed reagents/materials/analysis tools: PJF HK. Wrote the paper:
REHL AR AAM.
References
1. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, et al. (1998) Functional
significance of cell volume regulatory mechanisms. Physiol Rev 78: 247–306.
2. Kirk K, Strange K (1998) Functional properties and physiological roles of
organic solute channels. Annu Rev Physiol 60: 719–739.
Figure 10. Hypothetical explanation of the experimental data showing differences in taurine and glutamate release in vivo. A
reduction in medium osmolarity (Q[osm]e) in the rat cortex causes an increase in the extracellular levels of the excitatory amino acids glutamate and
aspartate and the sulfonic acid taurine via a mechanism sensitive to the anion channel blocker DNDS. Despite these similarities, the excitatory amino
acid and taurine release demonstrate different kinetics and are likely mediated by different transport pathways (1 and 2) and/or originate from
different cellular sources. The taurine pathway (1) but not the excitatory amino acid pathway (2) is activated by isoosmotic lowering of [NaCl]e.
Conversely, the swelling-activated excitatory amino acid release pathway (2) but not the taurine pathway (1) is potentiated by H2O2. Alternative
transport pathways that were considered in this study include: [Na
+]e-dependent taurine transporters (3), [Na
+]e/[K
+]i-dependent glutamate
transporters in neurons (4), and in astrocytes (5), which are sensitive to TBOA; and vesicular glutamate release (6), which is sensitive to the voltage-
gated Ca
2+ channel blocker Cd
2+. Based on the similarities of excitatory amino acid release in vivo and in cultured astrocytes, we speculate that
glutamate release in vivo largely originates from glial cells. Similarities between taurine release in vivo and in synaptosomes suggest that taurine
release may be of a neuronal origin.
doi:10.1371/journal.pone.0003543.g010
Cortical Amino Acid Release
PLoS ONE | www.plosone.org 10 October 2008 | Volume 3 | Issue 10 | e35433. Wehner F, Olsen H, Tinel H, Kinne-Saffran E, Kinne RK (2003) Cell volume
regulation: osmolytes, osmolyte transport, and signal transduction. Rev Physiol
Biochem Pharmacol 148: 1–80.
4. Fonnum F (1984) Glutamate: a neurotransmitter in mammalian brain.
J Neurochem 42: 1–11.
5. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72: 101–163.
6. Cartmell J, Schoepp DD (2000) Regulation of neurotransmitter release by
metabotropic glutamate receptors. J Neurochem 75: 889–907.
7. Kimelberg HK (1995) Current concepts of brain edema. Review of laboratory
investigations. J Neurosurg 83: 1051–1059.
8. Sykova E, Mazel T, Vargova L, Vorisek I, Prokopova-Kubinova S (2000)
Extracellular space diffusion and pathological states. Prog Brain Res 125:
155–178.
9. Mongin AA, Kimelberg HK (2005) Astrocytic swelling in neuropathology. In
Kettenmann H, Ransom B, eds. Neuroglia (2
nd edition). Oxford-New York:
Oxford University Press. pp 550–562.
10. Phillis JW, Song D, O’Regan MH (1997) Inhibition by anion channel blockers of
ischemia-evoked release of excitotoxic and other amino acids from rat cerebral
cortex. Brain Res 758: 9–16.
11. Seki Y, Feustel PJ, Keller RW Jr, Tranmer BI, Kimelberg HK (1999) Inhibition
of ischemia-induced glutamate release in rat striatum by dihydrokinate and an
anion channel blocker. Stroke 30: 433–440.
12. Kimelberg HK, Feustel PJ, Jin Y, Paquette J, Boulos A, et al. (2000) Acute
treatment with tamoxifen reduces ischemic damage following middle cerebral
artery occlusion. Neuroreport 11: 2675–2679.
13. Kimelberg HK, Jin Y, Charniga C, Feustel PJ (2003) Neuroprotective activity of
tamoxifen in permanent focal ischemia. J Neurosurg 99: 138–142.
14. Feustel PJ, Jin Y, Kimelberg HK (2004) Volume-regulated anion channels are
the predominant contributors to release of excitatory amino acids in the ischemic
cortical penumbra. Stroke 35: 1164–1168.
15. Zhang Y, Zhang H, Feustel PJ, Kimelberg HK (2008) DCPIB, a specific
inhibitor of volume regulated anion channels (VRACs), reduces infarct size in
MCAo and the release of glutamate in the ischemic cortical penumbra. Exp
Neurol 210: 514–520.
16. Mongin AA (2007) Disruption of ionic and cell volume homeostasis in cerebral
ischemia: The perfect storm. Pathophysiology 14: 183–193.
17. Strange K, Emma F, Jackson PS (1996) Cellular and molecular physiology of
volume-sensitive anion channels. Am J Physiol 270: C711–C730.
18. Okada Y (1997) Volume expansion-sensing outward-rectifier Cl
2 channel: fresh
start to the molecular identity and volume sensor. Am J Physiol Cell Physiol 273:
C755–C789.
19. Nilius B, Droogmans G (2003) Amazing chloride channels: an overview. Acta
Physiol Scand 177: 119–147.
20. Okada Y (2006) Cell volume-sensitive chloride channels: phenotypic properties
and molecular identity. Contrib Nephrol 152: 9–24.
21. Banderali U, Roy G (1992) Anion channels for amino-acids in Mdck cells.
Am J Physiol 263: C1200–C1207.
22. Jackson PS, Strange K (1993) Volume-sensitive anion channels mediate swelling-
activated inositol and taurine efflux. Am J Physiol 265: C1489–C1500.
23. Pasantes-Morales H, Moran J, Schousboe A (1990) Volume-sensitive release of
taurine from cultured astrocytes: properties and mechanism. Glia 3: 427–432.
24. Schousboe A, Sanchez OR, Moran J, Pasantes-Morales H (1991) Hyposmolar-
ity-induced taurine release in cerebellar granule cells is associated with diffusion
and not with high-affinity transport. J Neurosci Res 30: 661–665.
25. Sanchez-Olea R, Pena C, Moran J, Pasantes-Morales H (1993) Inhibition of
volume regulation and efflux of osmoregulatory amino acids by blockers of Cl
2
transport in cultured astrocytes. Neurosci Lett 156: 141–144.
26. Heacock AM, Kerley D, Gurda GT, Vantroostenberghe AT, Fisher SK (2004)
Potentiation of the osmosensitive release of taurine and D-aspartate from SH-
SY5Y neuroblastoma cells after activation of M3 muscarinic cholinergic
receptors. J Pharmacol Exp Ther 311: 1097–1104.
27. Cheema TA, Pettigrew VA, Fisher SK (2007) Receptor regulation of the
volume-sensitive efflux of taurine and iodide from human SH-SY5Y
neuroblastoma cells: Differential requirements for Ca
2+ and protein kinase C.
J Pharmacol Exp Ther 320: 1068–1077.
28. Olson JE, Li GZ (1997) Increased potassium, chloride, and taurine conductances
in astrocytes during hypoosmotic swelling. Glia 20: 254–261.
29. Junankar PR, Kirk K (2000) Organic osmolyte channels: A comparative view.
Cell Physiol Biochem 10: 355–360.
30. Franco R (2003) Osmosensitive taurine release: does taurine share the same
efflux pathway with chloride and other amino acid osmolytes? Adv Exp Med
Biol 526: 189–196.
31. Shennan DB (2008) Swelling-induced taurine transport: relationship with
chloride channels, anion-exchangers and other swelling-activated transport
pathways. Cell Physiol Biochem 21: 15–28.
32. Lambert IH, Hoffmann EK (1994) Cell swelling activates separate taurine and
chloride channels in Ehrlich mouse ascites tumor cells. J Membr Biol 142:
289–298.
33. Shennan DB, McNeillie SA, Curran DE (1994) The effect of a hyposmotic shock
on amino acid efflux from lactating rat mammary tissue: stimulation of taurine
and glycine efflux via a pathway distinct from anion exchange and volume-
activated anion channels. Exp Physiol 79: 797–808.
34. Stutzin A, Torres R, Oporto M, Pacheco P, Eguiguren AL, et al. (1999) Separate
taurine and chloride efflux pathways activated during regulatory volume
decrease. Am J Physiol Cell Physiol 277: C392–C402.
35. Mongin AA, Reddi JM, Charniga C, Kimelberg HK (1999) [
3H]Taurine and D-
[
3H]aspartate release from astrocyte cultures are differently regulated by tyrosine
kinases. Am J Physiol Cell Physiol 276: C1226–C1230.
36. Franco R, Quesada O, Pasantes-Morales H (2000) Efflux of osmolyte amino
acids during isovolumic regulation in hippocampal slices. J Neurosci Res 61:
701–711.
37. Tomassen SF, Fekkes D, De Jonge HR, Tilly BC (2004) Osmotic swelling-
provoked release of organic osmolytes in human intestinal epithelial cells.
Am J Physiol Cell Physiol 286: C1417–C1422.
38. Wade JV, Olson JP, Samson FE, Nelson SR, Pazdernik TL (1988) A possible
role for taurine in osmoregulation within the brain. J Neurochem 51: 740–745.
39. Lehmann A (1989) Effects of microdialysis-perfusion with anisoosmotic media
on extracellular amino acids in the rat hippocampus and skeletal muscle.
J Neurochem 53: 525–535.
40. Taylor DL, Davies SE, Obrenovitch TP, Doheny MH, Patsalos PN, et al. (1995)
Investigation into the role of N-acetylaspartate in cerebral osmoregulation.
J Neurochem 65: 275–281.
41. Morales I, Dopico JG, Sabate M, Gonzalez-Hernandez T, Rodriguez M (2007)
Substantia nigra osmoregulation: taurine and ATP involvement. Am J Physiol
Cell Physiol 292: C1934–C1941.
42. Estevez AY, O’Regan MH, Song D, Phillis JW (1999) Effects of anion channel
blockers on hyposmotically induced amino acid release from the in vivo rat
cerebral cortex. Neurochem Res 24: 447–452.
43. Mongin AA, Cai ZH, Kimelberg HK (1999) Volume-dependent taurine release
from cultured astrocytes requires permissive [Ca
2+]i and calmodulin.
Am J Physiol Cell Physiol 277: C823–C832.
44. Hajos F (1975) An improved method for the preparation of synaptosomal
fractions in high purity. Brain Res 93: 485–489.
45. Nedvetsky PI, Konev SV, Rakovich AA, Petrenko SV, Mongin AA (2000)
Effects of nitric oxide donors on Ca
2+-dependent [
14C]GABA release from brain
synaptosomes: The role of SH-groups. Biochemistry (Mosc) 65: 1027–1035.
46. Jentsch TJ, Stein V, Weinreich F, Zdebik AA (2002) Molecular structure and
physiological function of chloride channels. Physiol Rev 82: 503–568.
47. Abdullaev IF, Rudkouskaya A, Schools GP, Kimelberg HK, Mongin AA (2006)
Pharmacological comparison of swelling-activated excitatory amino acid release
and Cl
2 currents in rat cultured astrocytes. J Physiol 572: 677–689.
48. Chebabo SR, Hester MA, Jing J, Aitken PG, Somjen GG (1995) Interstitial
space, electrical resistance and ion concentrations during hypotonia of rat
hippocampal slices. J Physiol 487: 685–697.
49. Mongin AA, Aksentsev SL, Orlov SN, Konev SV (1997) Hypoosmotic shock
activates Ca
2+ channels in isolated nerve terminals. Neurochem Int 31: 835–843.
50. Tuz K, Pena-Segura C, Franco R, Pasantes-Morales H (2004) Depolarization,
exocytosis and amino acid release evoked by hyposmolarity from cortical
synaptosomes. Eur J Neurosci 19: 916–924.
51. Sharp T, Bramwell SR, Grahame-Smith DG (1990) Release of endogenous 5-
hydroxytryptamine in rat ventral hippocampus evoked by electrical stimulation
of the dorsal raphe nucleus as detected by microdialysis: sensitivity to
tetrodotoxin, calcium and calcium antagonists. Neuroscience 39: 629–637.
52. Liu X, Onaka T, Yagi K (2001) Facilitation of Ca
2+ store-dependent
noradrenaline release after an N-methyl-D-aspartate receptor antagonist in the
rat supraoptic nucleus. J Neuroendocrinol 13: 894–904.
53. Minami A, Takeda A, Nishibaba D, Takefuta S, Oku N (2001) Cadmium
toxicity in synaptic neurotransmission in the brain. Brain Res 894: 336–339.
54. Anderson CM, Swanson RA (2000) Astrocyte glutamate transport: review of
properties, regulation, and physiological functions. Glia 32: 1–14.
55. Shimamoto K, Lebrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, et al.
(1998) DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino
acid transporters. Mol Pharmacol 53: 195–201.
56. Rutledge EM, Kimelberg HK (1996) Release of [
3H]-D-aspartate from primary
astrocyte cultures in response to raised external potassium. J Neurosci 16:
7803–7811.
57. Trotti D, Danbolt NC, Volterra A (1998) Glutamate transporters are oxidant-
vulnerable: a molecular link between oxidative and excitotoxic neurodegener-
ation? Trends Pharmacol Sci 19: 328–334.
58. Kimelberg HK, Goderie SK, Higman S, Pang S, Waniewski RA (1990)
Swelling-induced release of glutamate, aspartate, and taurine from astrocyte
cultures. J Neurosci 10: 1583–1591.
59. Pasantes-Morales H, Murray RA, Sanchez-Olea R, Moran J (1994) Regulatory
volume decrease in cultured astrocytes. II. Permeability pathway to amino acids
and polyols. Am J Physiol 266: C172–C178.
60. Law RO (1994) Taurine efflux and the regulation of cell volume in incubated
slices of rat cerebral cortex. Biochim Biophys Acta 1221: 21–28.
61. Law RO (1996) Volume regulation and the efflux of amino acids from cells in
incubated slices of rat cerebral cortex. I. Characteristics of transport
mechanisms. Biochim Biophys Acta 1314: 34–42.
62. Bothwell JH, Rae C, Dixon RM, Styles P, Bhakoo KK (2001) Hypo-osmotic
swelling-activated release of organic osmolytes in brain slices: implications for
brain oedema in vivo. J Neurochem 77: 1632–1640.
63. Jackson PS, Morrison R, Strange K (1994) The volume-sensitive organic
osmolyte-anion channel VSOAC is regulated by nonhydrolytic ATP binding.
Am J Physiol 267: C1203–C1209.
Cortical Amino Acid Release
PLoS ONE | www.plosone.org 11 October 2008 | Volume 3 | Issue 10 | e354364. Roy G (1995) Amino-acid current through anion channels in cultured human
glial-cells. J Membr Biol 147: 35–44.
65. Boese SH, Wehner F, Kinne RK (1996) Taurine permeation through swelling-
activated anion conductance in rat IMCD cells in primary culture. Am J Physiol
271: F498–F507.
66. Franco R, Torres-Marquez ME, Pasantes-Morales H (2001) Evidence for two
mechanisms of amino acid osmolyte release from hippocampal slices. Pflugers
Arch 442: 791–800.
67. Waseem TV, Rakovich AA, Lavrukevich TV, Konev SV, Fedorovich SV (2005)
Calcium regulates the mode of exocytosis induced by hypotonic shock in isolated
neuronal presynaptic endings. Neurochem Int 46: 235–242.
68. Haskew RE, Mongin AA, Kimelberg HK (2002) Peroxynitrite enhances
astrocytic volume-sensitive excitatory amino acid release via a src tyrosine
kinase-dependent mechanism. J Neurochem 82: 903–912.
69. Haskew-Layton RE, Mongin AA, Kimelberg HK (2005) Hydrogen peroxide
potentiates volume-sensitive excitatory amino acid release via a mechanism
involving Ca
2+/calmodulin-dependent protein kinase II. J Biol Chem 280:
3548–3554.
70. Moran J, Maar T, Pasantes-Morales H (1994) Cell volume regulation in taurine
deficient cultured astrocytes. Adv Exp Med Biol 359: 361–367.
71. Lehmann A, Sandberg M (1990) In vivo substitution of choline for sodium
evokes a selective osmoinsensitive increase of extracellular taurine in the rat
hippocampus. J Neurochem 54: 126–129.
72. Saransaari P, Oja SS (2006) Characteristics of taurine release in slices from adult
and developing mouse brain stem. Amino Acids 31: 35–43.
73. Phillis JW, Song D, O’Regan MH (1999) Effects of hyperosmolarity and ion
substitutions on amino acid efflux from the ischemic rat cerebral cortex. Brain
Res 828: 1–11.
74. Calvert DT, Shennan DB (1998) Volume-activated taurine efflux from the in
situ perfused lactating rat mammary gland. Acta Physiol Scand 162: 97–105.
75. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65: 1–105.
76. Madsen S, Ottersen OP, Storm-Mathisen J (1985) Immunocytochemical
visualization of taurine: neuronal localization in the rat cerebellum. Neurosci
Lett 60: 255–260.
77. Storm-Mathisen J, Ottersen OP, Fu-Long T, Gundersen V, Laake JH, et al.
(1986) Metabolism and transport of amino acids studied by immunocytochem-
istry. Med Biol 64: 127–132.
78. Decavel C, Hatton GI (1995) Taurine immunoreactivity in the rat supraoptic
nucleus: prominent localization in glial cells. J Comp Neurol 354: 13–26.
79. Hussy N, Deleuze C, Desarmenien MG, Moos FC (2000) Osmotic regulation of
neuronal activity: a new role for taurine and glial cells in a hypothalamic
neuroendocrine structure. Prog Neurobiol 62: 113–134.
80. Pow DV, Sullivan R, Reye P, Hermanussen S (2002) Localization of taurine
transporters, taurine, and (3)H taurine accumulation in the rat retina, pituitary,
and brain. Glia 37: 153–168.
81. Phillis JW, Song D, O’Regan MH (1998) Tamoxifen, a chloride channel
blocker, reduces glutamate and aspartate release from the ischemic cerebral
cortex. Brain Res 780: 352–355.
82. Kohut JJ, Bednar MM, Kimelberg HK, McAuliffe TL, Gross CE (1992)
Reduction in ischemic brain injury in rabbits by the anion transport inhibitor L-
644,711. Stroke 23: 93–97.
83. Zhang Y, Jin Y, Behr MJ, Feustel PJ, Morrison JP, et al. (2005) Behavioral and
histological neuroprotection by tamoxifen after reversible focal cerebral
ischemia. Exp Neurol 196: 41–46.
84. Basarsky TA, Feighan D, MacVicar BA (1999) Glutamate release through
volume-activated channels during spreading depression. J Neurosci 19:
6439–6445.
85. Hyslop PA, Zhang Z, Pearson DV, Phebus LA (1995) Measurement of striatal
H2O2 by microdialysis following global forebrain ischemia and reperfusion in
the rat: correlation with the cytotoxic potential of H2O2 in vitro. Brain Res 671:
181–186.
86. Chan PH (2001) Reactive oxygen radicals in signaling and damage in the
ischemic brain. J Cereb Blood Flow Metab 21: 2–14.
Cortical Amino Acid Release
PLoS ONE | www.plosone.org 12 October 2008 | Volume 3 | Issue 10 | e3543